IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

QUARUS PHARMACEUTICALS LLP

LLPIN : AAS-3798|ROC: RoC-AhmedabadActive
Last Updated On : 17-03-2022
LLPINAAS-3798
LLP NameQUARUS PHARMACEUTICALS LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Ahmedabad
Date of Incorporation27-04-2020
Registered AddressBLOCK B, GF 12, TPS 14, SUMEL 6 JUPITER MILL COMPOUND, DUDHESHWAR AHMEDABAD Ahmedabad GJ 380013 IN
Email IDkunal.suthar13@gmail.com
Total Obligation of Contribution5,00,000
Main division of business activity to be carried out in India24
Description of main divisionManufacture of chemicals and chemical products
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
08737654KUNAL JAYANTILAL SUTHAR27-04-2020
08737655HETAL JIGNESH SUTHAR27-04-2020
QUARUS PHARMACEUTICALS LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Ahmedabad, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 27-04-2020 and last updated on 17-03-2022. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, QUARUS PHARMACEUTICALS LLP has a total contribution of INR 5,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is BLOCK B, GF 12, TPS 14, SUMEL 6 JUPITER MILL COMPOUND, DUDHESHWAR AHMEDABAD Ahmedabad GJ 380013 IN. Correspondence or inquiries may be sent to the official email address, kunal.suthar13@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.